AMERICAN SHARED HOSPITAL SERVICES Proceeds from (Repayments of) Restricted Cash, Financing Activities
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Proceeds from (Repayments of) Restricted Cash, Financing Activities of -$100.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities · last filed 2018-03-28
- AMERICAN SHARED HOSPITAL SERVICES proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2017-12-31 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2016-12-31 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2015-12-31 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from (repayments of) restricted cash, financing activities for fiscal 2017 was -$100.00K.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from (repayments of) restricted cash, financing activities for fiscal 2016 was -$200.00K.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from (repayments of) restricted cash, financing activities for fiscal 2015 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES proceeds from (repayments of) restricted cash, financing activities for fiscal 2014 was $0.00.
| Period end | Proceeds from (Repayments of) Restricted Cash, Financing Activities 3 month | Proceeds from (Repayments of) Restricted Cash, Financing Activities 9 month | Proceeds from (Repayments of) Restricted Cash, Financing Activities 12 month |
|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | -$100.00K 10-K · filed 2018-03-28 | |
| 2017-09-30 | -$100.00K 10-Q · filed 2017-11-13 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | -$200.00K 10-K · filed 2018-03-28 | |
| 2016-09-30 | -$200.00K 10-Q · filed 2017-11-13 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $0.00 10-K · filed 2018-03-28 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-10 | ||
| 2014-12-31 | $0.00 10-K · filed 2017-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |